Laos Healthcare Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Laos Healthcare Review.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 17, 2025

November 17, 2025

T-knife Therapeutics Files Clinical Trial Application for Phase 1 ATLAS Trial for TK-6302, a Supercharged PRAME-targeted T Cell Receptor Therapy

GlobeNewswire

November 17, 2025

NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts

GlobeNewswire

November 17, 2025

Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer’s Disease Pathology Following Porosome Reconstitution Therapy

GlobeNewswire

November 17, 2025

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

GlobeNewswire

November 17, 2025

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology

GlobeNewswire

November 17, 2025

Angiex Completes Financings Totaling $31 Million to Advance Phase 1 Dose Escalation of Nuclear-Delivered ADC AGX101 in Patients with Advanced Solid Tumors

GlobeNewswire

November 17, 2025

Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients

GlobeNewswire

November 17, 2025

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

GlobeNewswire

November 17, 2025

Metagenomi to Present at Jefferies Global Healthcare Conference in London

GlobeNewswire

November 17, 2025

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

GlobeNewswire

November 17, 2025

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

GlobeNewswire

November 17, 2025

Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

GlobeNewswire

November 17, 2025

Biogen and Stoke Therapeutics Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments

GlobeNewswire

November 17, 2025

Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies

GlobeNewswire

November 17, 2025

Immatics Announces Third Quarter 2025 Financial Results and Business Update

GlobeNewswire

November 17, 2025

Fortrea Appoints Agnieszka Gallagher as General Counsel

GlobeNewswire

November 17, 2025

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year

GlobeNewswire

November 17, 2025

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease

GlobeNewswire

November 17, 2025

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment

GlobeNewswire

November 17, 2025

Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

GlobeNewswire